Search results for "AGENTS"

showing 10 items of 7330 documents

The Influence of Thiol Reagents on the Isoenzyme Pattern of Plant L+Lactate Dehydrogenase (EC 1.1.1.27)

1978

Summary Lactate dehydrogenase from potato tubers was incubated together with various thiol reagents and the effect on the electrophoretic behavior of its isoenzymes studied. while disulfides, alkylating agents, and H202 did not alter the number and electrophoretic behavior of the isoenzymes of L + LDH, reduced glutathione and 2-mercaptoethanol led to an increase in the number of isoenzymes. The reaction was dependent on concentration and pH. On the other hand, cysteine and cysteamine had no such effect. Results are discussed in view of the possible secondary nature of the plant LDH isoenzymes.

Thiol Reagentsfood and beveragesGeneral MedicineGlutathioneIsozymeMolecular biologyIsoenzyme patternElectrophoresischemistry.chemical_compoundchemistryBiochemistryLactate dehydrogenaseCysteamineCysteineZeitschrift für Pflanzenphysiologie
researchProduct

Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric App…

2017

We report here on the synthesis of a series of mono-and dinuclear gold(I) complexes exhibiting sulfonated bis(NHC) ligands and novel hydroxylated mono(NHC) Au(I) compounds, which were also examined for their 'biological activities. Initial cell viability assays show strong antiproliferative activities of the hydroxylated mono(NHC) gold compounds (8 > 9 > 10) against 2008 human ovarian cancer cells even after 1 h incubation. In order to gain insight into the mechanism of biological action of the gold compounds, their effect on the pivotal cellular target seleno-enzyme thioredoxin reductase (TrxR), involved in the maintenance of intracellular redox balance, was investigated in depth. Th…

Thioredoxin Reductase 1AuranofinSilverStereochemistryThioredoxin reductaseThioredoxin Reductase 2WATER-SOLUBLE RUTHENIUM(II)Antineoplastic Agents010402 general chemistryG-quadruplexLigandsIN-VITRO CYTOTOXICITYLIGANDS SYNTHESIS01 natural sciencesInorganic Chemistrychemistry.chemical_compoundDrug StabilityThioredoxin Reductase 1Coordination ComplexesTHIOREDOXIN REDUCTASE INHIBITIONCell Line TumormedicineOrganogold CompoundsAnimalsHumansCRYSTAL-STRUCTURESPhysical and Theoretical ChemistryCANCER CELLSBIOLOGICAL-PROPERTIES010405 organic chemistryChemistryMOLECULAR-MECHANISMSDNA0104 chemical sciencesRatsG-QuadruplexesGlutathione ReductaseSolubilityBiological targetCancer cellPLATINUM ANTICANCER DRUGSMETAL-COMPLEXESGoldReactive Oxygen SpeciesCarbeneHydrophobic and Hydrophilic InteractionsOrganogold Compoundsmedicine.drugInorganic Chemistry
researchProduct

New Gold(I) Organometallic Compounds with Biological Activity in Cancer Cells

2014

N-Heterocyclic carbene gold(I) complexes bearing a fluorescent coumarin ligand were synthesized and characterized by various techniques. The compounds were examined for their antiproliferative effects in normal and tumor cells in vitro; they demonstrated moderate activity and a certain degree of selectivity. The compounds were also shown to efficiently inhibit the selenoenzyme thioredoxin reductase (TrxR), whereas they were poorly effective towards the glutathione reductase (GR) and glutathione peroxidase enzymes. Notably, {3-[(7-methoxy-2-oxo-2H-chromen-4-yl) methyl]-1-methylimidazol-2-ylidene}(tetra-O-acetyl-1-thio-beta-D-glucopyranosido) gold(I) (3) showed a pronounced inhibition of TrxR…

Thioredoxin reductaseGlutathione reductaseMECHANISMSInorganic Chemistrychemistry.chemical_compoundCoumarinsCHEMISTRYTARGETSN-HETEROCYCLIC CARBENESCancerchemistry.chemical_classificationSelenocysteineGlutathione peroxidaseGold; carbenes; coumarins; enzyme; CancerBiological activityLigand (biochemistry)EnzymesenzymechemistryBiochemistryCancer cellIodoacetamideCarbenesANTICANCER AGENTSCOMPLEXESGold
researchProduct

Drug-related falls and thraumatic brain injury in very old patients: antithrombotic drugs as new potential culpruit factors

2022

NA

Thrauma.Fibrinolytic AgentsRisk FactorsBrain InjuriesFallEmergency MedicineInternal MedicineHumansBrain injuryDrugAntitrhombotic drugInternal and Emergency Medicine
researchProduct

Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.

2004

Glycoproteins on epithelial tumor cells often exhibit aberrant glycosylation profiles. The incomplete formation of the glycan side chains resulting from a down-regulated glucosamine transfer and a premature sialylation results in additional peptide epitopes, which become accessible to the immune system in mucin-type glycoproteins. These cancer-specific structure alterations are considered to be a promising basis for selective immunological attack on tumor cells. Among the tumor-associated saccharide antigens, the (2,3)-sialyl-T antigen has been identified as the most abundant glycan, found in several different carcinoma cell lines. According to a linear biomimetic strategy, the (2,3)-sialyl…

ThreonineGlycanMagnetic Resonance SpectroscopyMolecular Sequence DataCancer VaccinesCatalysisEpitopeMass SpectrometryImmune systemAntigenAntigens NeoplasmBiomimeticsMUC1Chromatography High Pressure LiquidGlycoproteinschemistry.chemical_classificationbiologyMucin-4Organic ChemistryMucinMucin-1GlycopeptidesMucinsGeneral ChemistryGlycopeptidecarbohydrates (lipids)chemistryBiochemistryCarbohydrate SequenceTandem Repeat Sequencesbiology.proteinIndicators and ReagentsGlycoproteinChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura

2020

Introduction: Acquired thrombotic thrombocytopenic purpura (aTTP) is a thrombotic microangiopathy caused by inhibitory autoantibodies against ADAMTS13 protein. Until recently, the combination of plasma exchange (PEX) and immunosuppression has been the standard front-line treatment in this disorder. However, aTTP-related mortality, refractoriness, and relapse are still a matter of concern. Areas covered: The better understanding of the pathophysiological mechanisms of aTTP has allowed substantial improvements in the diagnosis and treatment of this disease. Recently, the novel anti-VWF nanobody caplacizumab has been approved for acute episodes of aTTP. Caplacizumab is capable to block the adh…

Thrombotic microangiopathyExacerbationvirusesmedicine.medical_treatmentADAMTS13 ProteinDiseaseBioinformaticsAutoantigens03 medical and health sciencesPlatelet Adhesiveness0302 clinical medicineFibrinolytic AgentsProtein DomainsCrotalid Venomsvon Willebrand FactormedicineHumansImmunologic FactorsMulticenter Studies as TopicLectins C-TypeMolecular Targeted TherapyDrug ApprovalClinical Trials as TopicAcquired Thrombotic Thrombocytopenic PurpuraPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryStandard treatmentfungiImmunosuppressionDrugs InvestigationalHematologyAptamers NucleotideSingle-Domain Antibodiesbiochemical phenomena metabolism and nutritionmedicine.diseaseCombined Modality TherapyRecombinant ProteinsADAMTS13AcetylcysteineTreatment Outcome030220 oncology & carcinogenesisDrug Therapy CombinationCaplacizumabbusinessImmunosuppressive Agents030215 immunologyExpert Review of Hematology
researchProduct

Fragments of β-thymosin from the sea urchin Paracentrotus lividus as potential antimicrobial peptides against staphylococcal biofilms.

2012

The immune mediators in echinoderms can be a potential source of novel antimicrobial peptides (AMPs) applied toward controlling pathogenic staphylococcal biofilms that are intrinsically resistant to conventional antibiotics. The peptide fraction5 kDa from the cytosol of coelomocytes of the sea urchin Paracentrotus lividus (5-CC) was tested against a group of Gram-positive and Gram-negative pathogen reference strains. The 5-CC of P. lividus was active against all planktonic-tested strains but also showed antibiofilm properties against staphylococcal strains. Additionally, we demonstrated the presence of three small peptides in the 5-CC belonging to segment 9-41 of a P. lividusβ-thymosin. The…

ThymosinAnti-Infective AgentsBiofilmsSea UrchinsStaphylococcusantibiofilm agents; antimicrobial peptides (AMPs); staphylococcal biofilmsstaphylococcal biofilmsAnimalsMicrobial Sensitivity TestsSettore BIO/19 - Microbiologia Generaleantibiofilm agentantimicrobial peptides (AMPs)Annals of the New York Academy of Sciences
researchProduct

A study of electron transfer in Ru(dcbpy)2(NCS)2 sensitized nanocrystalline TiO2 and SnO2 films induced by red-wing excitation.

2008

Excited state dynamics and electron transfer from the Ru(dcbpy)2(NCS)2 (RuN3) sensitizer to semiconductor nanoparticles were studied using time-resolved femtosecond absorption spectroscopy. We found that excitation of the red wing of the absorption spectrum of the sensitizer populates the (3)MLCT state directly, both in solution and attached on semiconductor nanoparticle films. Electron injection is slowed down and becomes gradually less efficient as excitation moves towards red from the absorption maximum at 535 nm. At 675 nm the injection is non-exponential and characterized by 5, 30 and 180 ps time constants. The non-exponential electron injection observed is assigned to injection from a…

Time FactorsAbsorption spectroscopyPhotochemistrySurface PropertiesAnalytical chemistryGeneral Physics and AstronomyElectronsSensitivity and SpecificityRutheniumElectron transferOrganometallic CompoundsPhysical and Theoretical ChemistryTriplet stateAbsorption (electromagnetic radiation)Coloring AgentsTitaniumChemistrybusiness.industryLasersSpectrum AnalysisTin CompoundsMembranes ArtificialNanocrystalline materialNanostructuresKineticsSemiconductorSemiconductorsExcited stateFemtosecondbusinessThiocyanatesPhysical chemistry chemical physics : PCCP
researchProduct

Barriers to insulin initiation and intensification and how to overcome them

2009

Summary Aims:  To review published evidence and clinical experience of the perceived barriers to insulin initiation and intensification and to develop solutions for patient management. Method:  Literature review and workshop discussions. Results:  Many patients with diabetes fail to achieve targets for glycaemic control because of inappropriate use of insulin. Patients and health care professionals face many potential barriers to insulin initiation and intensification in primary care. These can be categorised as low motivation, lack of familiarity or experience and time constraints. Conclusion:  Solutions should be tailored to different health care settings. Strategies include improving edu…

Time FactorsAttitude of Health Personnelmedicine.medical_treatmentMEDLINEPrimary careWorkloadPatient satisfactionNursingAcquired immunodeficiency syndrome (AIDS)Patient Education as TopicHealth caremedicineHumansHypoglycemic AgentsInsulinbusiness.industryInsulinWorkloadGeneral MedicineFearLow motivationmedicine.diseaseDiabetes Mellitus Type 2Patient SatisfactionbusinessFamily Practice
researchProduct

Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation.

2000

Many in vitro studies have used cell cultures to focus on the relationships between cyclo-oxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) isoforms. We have investigated the time-course of regulation and the role of COX-2 and iNOS in a model of experimental inflammation in mice, the air pouch injected with zymosan. This study demonstrates that there is an early acute phase (4 h) mediated mainly by eicosanoids, with high levels of prostaglandin E2 (PGE2) produced by cyclo-oxygenase-1. In addition, in the later phase (from 12 h) there is a participation of nitric oxide (NO) and PGE2 accompanied by co-induction of both iNOS and COX-2. These enzymes were detected in migrating leuk…

Time FactorsBlotting WesternAnti-Inflammatory AgentsFluorescent Antibody TechniqueNitric Oxide Synthase Type IIInflammationPharmacologyDexamethasoneDinoprostoneNitric oxidechemistry.chemical_compoundMiceIn vivomedicineLeukocytesAnimalsCyclooxygenase InhibitorsProstaglandin E2NitritePharmacologyInflammationbiologyCyclooxygenase 2 InhibitorsZymosanZymosanGeneral MedicineExudates and TransudatesNitric oxide synthaseIsoenzymeschemistryBiochemistryCell cultureCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesEnzyme Inductionbiology.proteinEicosanoidsFemalemedicine.symptomNitric Oxide SynthaseColchicinemedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct